547
Participants
Start Date
September 30, 2007
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2015
Dasatinib
Tablets, oral, dasatinib 50-140 mg once daily (QD)
Imatinib
Tablets, oral, imatinib 200-800 mg, QD
Local Institution, Lima
Local Institution, Lima
Local Institution, Buenos Aires
Local Institution, Vienna
Local Institution, Budapest
Local Institution, Brussels
Local Institution, Capital Federal
Local Institution, Waratah
Local Institution, Debrecen
Local Institution, Brisbane
Local Institution, Greenslopes
Local Institution, Innsbruck
Local Institution, Bruges
Local Institution, Aarhus
Local Institution, Orbassano (to)
Local Institution, Campinas
Local Institution, Berlin
Local Institution, Mexico City
Local Institution, A Coruña
Local Institution, Jaú
Local Institution, Rostock
Local Institution, Monza (mb)
Local Institution, Pavia
Local Institution, Madrid
Local Institution, Madrid
Local Institution, Málaga
Local Institution, Brest
Local Institution, Toulouse
Local Institution, Krakow
Local Institution, Oviedo
Local Institution, Montpellier
Local Institution, Rennes
Local Institution, Salamanca
Local Institution, Kayseri
Local Institution, Bologna
Local Institution, Nantes
Local Institution, Valencia
Local Institution, Vandœuvre-lès-Nancy
Local Institution, Thessaloniki
Local Institution, Lille
Local Institution, Poznan
Local Institution, Monterrey
Local Institution, Strasbourg
Local Institution, Pierre-Bénite
Local Institution, Tübingen
Local Institution, Paris
Local Institution, Paris
Local Institution, Curitiba
Local Institution, Culiacán
Local Institution, Poitiers
Local Institution, Limoges
Local Institution, Ulm
Local Institution, Catania
Molecular Md, Portland
Local Institution, Beijing
Local Institution, Moscow
Local Institution, Singapore
Local Institution, Saint Petersburg
Local Institution, Shanghai
Local Institution, Tianjin
Local Institution, Rostov-on-Don
Local Institution, Fuzhou
Local Institution, Ahmedabad
Local Institution, Mumbai
Local Institution, Mumbai
Local Institution, Mumbai
Local Institution, Vellore
Local Institution, Kochi
Local Institution, Trivandrum
Local Institution, Shinagawa-ku
Local Institution, Kamogawa-shi
Local Institution, Kyoto
Local Institution, Okayama
Local Institution, Rio de Janeiro
Local Institution, Capital Federal
Local Institution, Perth
Local Institution, São Paulo
Local Institution, São Paulo
Local Institution, Santiago
Local Institution, Colombia
Local Institution, Bogotá
Local Institution, Sendai
Local Institution, Arequipa
Local Institution, Brno
Local Institution, Hradec Králové
Local Institution, Olomouc
Local Institution, Prague
Local Institution, Roma
Local Institution, Roma
Local Institution, Nagoya
Local Institution, Fukuoka
Local Institution, Morioka
Local Institution, Kagoshima
Local Institution, Yokohama
Local Institution, Osaka
Local Institution, Bunkyo-ku
Local Institution, Mexico City
Local Institution, Mexico, D. F.
Local Institution, Groningen
Local Institution, Nijmegen
Local Institution, Chorzów
Local Institution, Lodz
Local Institution, Warsaw
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Barcelona
Local Institution, Barcelona
Local Institution, Barcelona
Local Institution, Ankara
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY